首页> 外文期刊>Current Eye Research >Effects of instillation of eyedrops containing disulfiram and hydroxypropyl-β-cyclodextrin inclusion complex on endotoxin-induced uveitis in rats
【24h】

Effects of instillation of eyedrops containing disulfiram and hydroxypropyl-β-cyclodextrin inclusion complex on endotoxin-induced uveitis in rats

机译:滴加双硫仑和羟丙基-β-环糊精包合物的滴眼液对内毒素性葡萄膜炎的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate the anti-inflammatory effects of the instillation of disulfirum (DSF) eyedrops that enhance solubility using 2-hydroxypropyl- β-cyclodextrin (HPβCD) and hydroxypropylmethylcellulose (HPMC) on endotoxin-induced uveitis (EIU) in rats and mechanisms related to ocular inflammation. Methods: EIU was induced in male Lewis rats by subcutaneous injection of 200 μg lipopolysaccharide (LPS). DSF (0.125%, 0.25% and 0.5%) or commercially available 0.05% dexamethasone (Dexa) was topically applied to both eyes of rats 1 hour before, immediately after, and 1 and 2 hours after injection of LPS. The aqueous humor (AqH) was collected 24 hours after LPS injection, and the number of infiltrating cells, protein concentration, and levels of tumor necrosis factor-α (TNF-α), nitric oxide (NO) and prostaglandin E2 (PGE2) were determined. Immunohistochemical analysis of the iris ciliary body (ICB) cells was performed to determine the expression of activated nuclear factor κB (NF-κB), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Results: The topical administration with DSF suppressed, in a dose-dependent manner, the number of inflammatory cells, the protein concentration, and the levels of NO, TNF-α and PGE2 in the AqH and improved the histologic status of the ocular tissue. The anti-inflammatory potency of 0.5% DSF treatment was as strong as that of 0.05% Dexa. Topical DSF treatment also suppressed the activated NF-κB 3 hours after LPS injection, and iNOS and COX-2 expression in the ICB 24 hours after LPS injection. Conclusions: The present results demonstrate that the topical instillation of DSF eyedrops suppresses the inflammation in EIU, suggesting a possible novel approach for the treatment of ocular inflammation.
机译:目的:研究2-羟丙基-β-环糊精(HPβCD)和羟丙基甲基纤维素(HPMC)滴注二硫滴眼液(DSF)增强溶解性的抗炎作用及其相关机制眼部发炎。方法:皮下注射200μg脂多糖(LPS)在雄性Lewis大鼠中诱发EIU。在注射LPS之前1小时,之后以及之后1和2小时,将DSF(0.125%,0.25%和0.5%)或市售的0.05%地塞米松(Dexa)局部施用于大鼠的两只眼睛。注射LPS后24小时收集房水(AqH),其浸润细胞数,蛋白质浓度以及肿瘤坏死因子-α(TNF-α),一氧化氮(NO)和前列腺素E2(PGE2)的水平为决心。进行虹膜睫状体(ICB)细胞的免疫组织化学分析,以确定活化核因子κB(NF-κB),诱导型一氧化氮合酶(iNOS)和环氧合酶2(COX-2)的表达。结果:局部给予DSF可以剂量依赖性地抑制AqH中炎性细胞的数量,蛋白质浓度以及NO,TNF-α和PGE2的水平,并改善了眼组织的组织学状态。 0.5%DSF处理的抗炎效力与0.05%Dexa一样强。局部DSF处理还可以在LPS注射后3小时抑制活化的NF-κB,并在LPS注射后24小时抑制ICB中的iNOS和COX-2表达。结论:目前的结果表明,局部滴注DSF滴眼液可抑制EIU中的炎症,这为治疗眼部炎症提供了一种可能的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号